November 2013 FDA Recall Drug by Sigma-tau Pharmaceuticals, Inc.
D-736-2014 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Sigma-tau Pharmaceuticals, Inc. on November 1, 2013 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-736-2014

Reason for Recall
Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.
Initiated
11-01-2013
Reported
01-22-2014
Quantity
7479 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Sigma-Tau Pharmaceuticals, Inc.
PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-tau PHARMACEUTICALS INC, 9841 Washingtonian Blvd, Gaithersburg, MD 20878 NDC 54482-301-01

Batch or Lot Expiration Information

Lot# 3012A, 3013A, 30138, Exp. 11/13
Lot# 3014A, 3014A CLIN, Exp. 12/13